FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3]

Introducing the FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3], a cutting-edge product designed to revolutionize the field of immunology. This antibody, meticulously developed by our team of experts, offers unparalleled specificity and sensitivity in detecting CD274/PD-L1 expression in human samples.

With its fluorescein isothiocyanate (FITC) conjugation, this antibody enables precise visualization and analysis of CD274/PD-L1 expression through flow cytometry and immunofluorescence techniques. Its exceptional binding affinity ensures accurate identification and quantification of CD274/PD-L1, facilitating comprehensive investigations into immune responses and cancer immunotherapy.

The FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3] exhibits exceptional performance across a wide range of applications, including immunohistochemistry, immunoprecipitation, and western blotting. Its robust and reliable performance guarantees consistent and reproducible results, empowering researchers to delve deeper into the intricate mechanisms underlying immune regulation and tumor evasion.

This antibody's unique formulation, coupled with its exceptional specificity, renders it an invaluable tool for both basic research and clinical applications. Its compatibility with various sample types, including formalin-fixed paraffin-embedded tissues, further enhances its versatility and utility in diverse experimental settings.

We take immense pride in delivering this state-of-the-art antibody, meticulously manufactured under stringent quality control measures to ensure utmost reliability and performance. Each batch undergoes rigorous testing to guarantee consistent quality, providing researchers with the confidence to pursue groundbreaking discoveries.

In summary, the FITC Anti-Human CD274/PD-L1 Antibody[29E.2A3] represents a breakthrough in immunological research, offering unrivaled specificity, sensitivity, and versatility. With its exceptional performance and reliability, this antibody is poised to revolutionize the understanding of immune regulation and cancer immunotherapy. Embrace the future of immunology with this remarkable product and unlock new frontiers in scientific exploration.